Hormone therapy for transgender individuals has been shown in medical literature to be safe, when supervised by a qualified medical professional [REF].
Preventative care for transgender people includes the monitoring of risk factors that are associated with hormone replacement therapy, such as prolactin levels in transgender women and polycythemia levels in transgender men [REF].